Citius Pharmaceuticals, Inc. Common Stock (NASDAQ: CTXR) last traded at $0.493, down 1.32% on the session. The quote above updates while this page is open; the figures below are drawn from Citius Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Citius Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker CTXR. Its market capitalisation is $13.53 million.
Valuation measures for Citius Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $13.53M |
|---|---|
| Enterprise value | $62.87M |
| Price / book | 0.20 |
| Beta | 2.67 |
Trailing-twelve-month figures tagged in Citius Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$58.17M |
| EPS (TTM) | -$1.68 |
|---|
| Return on equity | -87.32% |
|---|
| Cash | $17.01M |
|---|
Range and volume for CTXR over the past 52 weeks.
| 52-week high | $2.19 |
|---|---|
| 52-week low | $0.469 |
| Volume | 119.3K |
| Average volume | 522.6K |
| Previous close | $0.499 |
Invest a chosen dollar amount in Citius Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CTXR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.